Efficacy and safety of OnabotulinumtoxinA in an OpenLabel study for the prophylactic treatment of chronic migraine in adult patients: COMPEL

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: 596a04c18eb65a3c21ce69f3d9a7428fe365c871
First added on: Feb 08, 2025